Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).
about
The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A?Determination of antazoline hydrochloride in rat plasma and excreta by reversed-phase ion-pair chromatography and its application to pharmacokinetics.Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
P2860
Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clinical efficacy of antazolin ...... olled study (the AnPAF Study).
@ast
Clinical efficacy of antazolin ...... olled study (the AnPAF Study).
@en
type
label
Clinical efficacy of antazolin ...... olled study (the AnPAF Study).
@ast
Clinical efficacy of antazolin ...... olled study (the AnPAF Study).
@en
prefLabel
Clinical efficacy of antazolin ...... olled study (the AnPAF Study).
@ast
Clinical efficacy of antazolin ...... olled study (the AnPAF Study).
@en
P2093
P2860
P921
P356
P1433
P1476
Clinical efficacy of antazolin ...... rolled study (the AnPAF Study)
@en
P2093
Aleksander Maciag
Hanna Szwed
Ilona Kowalik
Mariusz Pytkowski
Rafal Dabrowski
P2860
P2888
P356
10.1186/1745-6215-13-162
P577
2012-09-11T00:00:00Z
P5875
P6179
1016184566